CNBC June 30, 2021
Key Points
– CRISPR gene editing, which slices DNA to treat diseases, had its first-ever systemic delivery in a human body.
– Jennifer Doudna, who won the 2020 Nobel Prize in chemistry for her work on CRISPR, called the early success of the technology “one of the fastest rollouts I think of technology from the fundamental, initial science to an actual application.”
– Intellia Therapeutics, the biotech she co-founded, has seen its stock rise over 100% this month.
Gene-editing technology CRISPR reached a major milestone this past weekend, completing its first systemic delivery as a medicine to a human body.
CRISPR, or clustered regularly interspaced short palindromic repeats, effectively cuts genomes and slices DNA to treat genetic diseases.
The latest...
Today's Sponsors
Today's Sponsor